Effects of basic fibroblast growth factor on the differentiation, growth, and viability of a new human medulloblastoma cell line (UM-MB1)

American Journal of Pathology

Volumn 151, Issue 3, 1997, Pages 867-881

  Kenigsberg, Rhoda L ^a   Hong, Yanguo ^a   Yao, Hong ^a   Lemieux, Nicole ^a   Michaud, Jean ^a   Tautu, Constantin ^a   Théorêt, Yves ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; MICROTUBULE ASSOCIATED PROTEIN 1; MICROTUBULE ASSOCIATED PROTEIN 5; NEURON SPECIFIC ENOLASE; RECOMBINANT BASIC FIBROBLAST GROWTH FACTOR; SYNAPTOPHYSIN;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CASE REPORT; CELL CYCLE G1 PHASE; CELL DEATH; CELL DIFFERENTIATION; CELL GROWTH; CELL VIABILITY; CHROMATIN CONDENSATION; FEMALE; FLOW CYTOMETRY; GROWTH CONE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; KARYOTYPING; MEDULLOBLASTOMA; NEUROFILAMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; TRIPLOIDY; ULTRASTRUCTURE;

ANTIGENS, DIFFERENTIATION; APOPTOSIS; CELL DIFFERENTIATION; CELL DIVISION; CELL LINE; CELL LINEAGE; CELL SURVIVAL; CEREBELLAR NEOPLASMS; CHILD, PRESCHOOL; CHOLINE O-ACETYLTRANSFERASE; FEMALE; FIBROBLAST GROWTH FACTOR 2; GLUTAMATE DECARBOXYLASE; HUMANS; IMMUNOHISTOCHEMISTRY; KARYOTYPING; KI-67 ANTIGEN; MEDULLOBLASTOMA; MICROSCOPY, ELECTRON; MICROSCOPY, FLUORESCENCE; NEURITES; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR CELLS, CULTURED;

EID: 0030966331     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (74)

1. Tomlinson FH, Scheithauer BW, Meyer FB, Smithson WA, Shaw EG, Miller GM, Groover RV: Medulloblastoma. I. Clinical, diagnostic, and therapeutic overview. J Child Neurol 1992; 7:142-155
2. Hirsch J-F, Hoppe-Hirsch E: Medulloblastoma. Adv Tech Stand Neurosurg 1993, 20:165-196
3. Friedman HS, Burger PC, Bigner SH, Trojanowski JQ, Wikstrand CJ, Halperin EC, Bigner DD: Establishment and characterization of the human medulloblastoma cell line and transplantable xenograft D283 MED. J Neuropathol Exp Neurol 1985, 44:592-605
4. Friedman HS, Burger PC, Bigner SH, Trojanowski JQ, Brodeur GM, He X, Wikstrand CJ, Kurtzburg J, Berens ME, Halperin EC, Bigner DD: Phenotypic and genotypic analysis of a human medulloblastoma cell line and transplantable xenograft (D341 Med) demonstrating amplifications of c-myc. Am J Pathol 1988, 130:472-484
5. Jacobsen PF, Jenkyn DJ, Papadimitriou JM: Establishment of a human medulloblastoma cell line and its heterotransplantation into nude mice. J Neuropathol Exp Neurol 1985, 44:472-485
6. Trojanowski JQ, Friedman HS, Burger PC, Bigner DD: A rapidly dividing human medulloblastoma cell line (D283 MED) expresses all three neurofilament subunits. Am J Pathol 1985, 126:358-363
7. Trojanowski JQ, Kelsten ML, Lee VM-Y: Phosphate dependent and independent neurofilament epitopes are expressed throughout the cell cycle in rapidly dividing human medulloblastoma cells. Am J Pathol 1989, 135:747-758
8. He X, Skapek S, Wikstrand CJ, Friedman HS, Trojanowski JQ, Kemstead JT, Coakham HB, Bigner SH, Bigner DD: Phenotypic analysis of four human medulloblastoma cell lines and transplantable xenografts. J Neuropathol Exp Neurol 1989, 48:48-68
9. He X, Wikstrand CJ, Friedman HS, Bigner SH, Pleasure S, Trojanowski JQ, Bigner DD: Antigenic profiles of newly established medulloblastoma cell lines (D283 Med, D425 Med, and D458 Med) and their transplantable xenografts. Lab Invest 1991, 64:833-843
10. Tamamura K, Shimizu K, Yamada M, Okamoto Y, Matsui Y, Park KC, Mabuchi E, Moriuchi S, Mogami H: Expression of major histocompatibility complex on human medulloblastoma cells with neuronal differentiation. Cancer Res 1989, 49:5380-5384
11. Pietsch T, Scharmann T, Fonatsch C, Schmidt D, Öckler R, Freihoff D, Albrecht S, Wiestler OD, Zeltzer P, Riehm H: Characterization of five new cell lines derived from human primitive neuroectodermal tumors of the central nervous system. Cancer Res 1994, 54:3278-3287
12. Keles GE, Berger MS, Srinivasan J, Kolstoe DD, Bobola MS, Silber JR: Establishment and characterization of four human medulloblastoma-derived cell lines. Oncol Res 1995, 7:493-503
13. Janss AJ, Yachnis AT, Silber JH, Trojanowski JQ, Lee VM-Y, Sutton LN, Perilongo G, Rorke LB, Phillips PC: Glial differentiation predicts poor clinical outcome in primitive neuroectodermal brain tumors. Ann Neurol 1996, 39:481-489
14. Stevenson L, Echlin R: The nature and origin of some tumors of the cerebellum (medulloblastoma). Arch Neurol Psychiat 1934, 31:93-109
15. Rorke LB: The cerebellar medulloblastoma and its relationship to primitive neuroectodermal tumors. J Neuropathol Exp Neurol 1983, 42:1-15
16. Gould VE, Jansson DS, Molenaar WM, Rorke LB, Trojanowski JQ, Lee VM-Y, Packer RJ, Frank WW: Primitive neuroectodermal tumors of the central nervous system: patterns of expression of neuroendocrine markers, and all classes of intermediate filament proteins. Lab Invest 1990, 62:498-509
17. Lim R, Hicklin DJ, Ryken TC, Han XM, Liu KN, Miller JF, Baggenstoss BA: Suppression of glioma growth in vitro and in vivo by glia maturation factor. Cancer Res 1986, 46:5241-5247
18. Hondermarck H, McLaughlin CS, Patterson SD, Bradshaw RA: Early changes in protein synthesis induced by basic fibroblast growth factor, nerve growth factor, and epidermal growth factor in PC12 pheochromocytoma cells. Proc Natl Acad Sci USA 1994, 20:9377-9381
19. Counis MF, Chaudun E, Allinquat B, Muel AS, Sanwal M, Skidmore C, Courtis Y: The lens: a model for chromatin degradation studies in terminally differentiating cells. Int J Biochem 1989, 21:235-242
20. Farzaneh F, Zalin R, Brill D, Shall S: DNA strand breaks and ADP-ribosyl transferase activation during cell differentiation. Nature 1982, 300:363-366
21. 2+-dependent endonuclease activity during the early stages of murine erythroleukaemic cell differentiation. Proc Natl Acad Sci USA 1984, 81:7461-7465
22. 1 arrest. J Clin Invest 1992, 89:954-960
23. El-Husseini AE, Patterson JA, Shiu RP: Basic fibroblast growth factor (bFGF) and two of its receptors, FGFR1 and FGFR2: gene expression in the rat brain during postnatal development as determined by quantitative RT-PCR. Mol Cell Endocrinol 1994, 104:191-200
24. Matsuda S, Ii Y, Desaki J, Yoshimura H, Okumura N, Sakanaka M: Development of Purkinje cell bodies and processes with basic fibroblast growth factor-like immunoreactivity in the rat cerebellum. Neuroscience 1994, 59:651-662
25. Lemieux N, Richer C-L: Synchronization of cultured retinoblastoma cells for high resolution chromosomes showing up to 1000 bands. Cancer Genet Cytogenet 1989, 40:55-63
26. Fonnum F: A rapid radiochemical method for determination of choline acetyltransferase. J Neurochem 1975, 24:407-109
27. Wilson SH, Shrier BK, Farber JL, Thompson EJ, Rosenberg RN, Blume AJ, Nirenberg MW: Markers for gene expression in cultured cells from the nervous system. J Biol Chem 1972, 247:3159-3169
28. Mazzoni IE, Kenigsberg RL: Transforming growth factor α differentially affects GABAergic and cholinergic neurons in rat medial septal cell cultures. Brain Res 1996, 707:88-99
29. Benito A, Grillot D, Nuñez G, Fernândez-Luna JS: Regulation and function of Bcl-2 during differentiation-induced cell death in HL-60 promyelocytic cells. Am J Pathol 1995, 146:481-490
30. Belloc F, Dumain P, Boisseau MR, Jalloustre C, Reiffers J, Bernard P, Lacombe F: A flow cytometric method using Hoechst 33342 and propidium iodide for simultaneous cell cycle analysis and apoptosis determination in unfixed cells. Cytometry 1994, 17:59-65
31. Lizard G, Fournel S, Genestier L, Dhedin N, Chaput C, Flacher M, Mutin M, Panaye G, Revillard J-P: Kinetics of plasma membrane and mitochondrial alterations in cells undergoing apoptosis. Cytometry 1995, 21:275-283
32. Kuznetsov SA, Rodionov VI, Nadezhdina ES, Murphy DB, Gelfand VI: Identification of a 34-kD polypeptide as a light chain of microtubule-associated protein-1 (MAP-1) and its association with a MAP-1 peptide that binds to microtubules. J Cell Biol 1986, 102:1060-1066
33. Riederer B, Cohen R, Matus A: MAP5: a novel brain microtubule-associated protein under strong developmental regulation. J Neurocytol 1986, 15:763-775
34. Tucker RP, Binder LI, Matus AI: Neuronal microtubule-associated proteins in the embryonic avian spinal cord. J Comp Neurol 1988, 271:44-55
35. Kasa P: The cholinergic systems in brain and spinal cord. Prog Neurobiol 1986, 26:211-272
36. Court JA, Perry EK, Spurden D, Griffiths M, Kerwin JM, Morris CM, Johnson M, Oakley AE, Birdsall NJM, Clementi F, Perry RH: The role of the cholinergic system in the development of the human cerebellum. Brain Res Dev Brain Res 1995, 90:159-167
37. Ghez C: The cerebellum. Principles of Neural Science. Edited by ER Kandel, JH Schwartz, TM Jessel. New York, Elsevier 1991, pp 626-645
38. Peters P, Palay SJ, Webster HF: The Fine Structure of the Nervous System: Neurons and Their Supporting Cells, ed 3. New York, Oxford University Press, 1991, p 494
39. Collins RJ, Harmon BV, Gobé GC, Kerr JFR: Internucleosomal DNA cleavage should not be the sole criterion for identifying apoptosis. Int J Radiat Biol 1992, 61:451-453
40. Wyllie AH, Kerr JFR, Currie AR: Cell death: the significance of apoptosis. Int Rev Cytol 1980, 68:251-305
41. Arends MJ, Wyllie AH: Apoptosis: mechanisms and roles in pathology. Int Rev Exp Pathol 1991, 32:223-254
42. Ghadially FN: Ultrastructural Pathology of the Cell and Matrix, ed 3, vol 2. London, Butterworths 1988, pp 974-977
43. Mannoji H, Takeshita I, Fukui M, Ohta M, Kitamura K: Glial fibrillary acidic protein in medulloblastoma. Acta Neuropathol 1981, 55:63-69
44. Molenaar WM, Jansson DS, Gould VE, Rorke LB, Franke WW, Lee VM-Y, Packer JR, Trojanowski JQ: Molecular markers on primitive neuroectodermal tumors and other pediatric central nervous system tumors: monoclonal antibodies to neuronal and glial antigens distinguish subsets of primitive neuroectodermal tumors. Lab Invest 1989, 61:635-643
45. Palmer JO, Kasselberg AG, Netsky MG: Differentiation of medulloblastoma: studies including immunohistochemical localization of glial fibrillary acidic protein. J Neurosurg 1981, 55:161-169
46. Schindler E, Gullotta F: Glial fibrillary acidic protein in medulloblastomas and other embryonic CNS tumors of children. Virchows Arch 1983, 398:263-275
47. Coffin CM, Mukai K, Dehner LP: Glial differentiation in medulloblastomas: histogenic insight, glial resection, or invasion of brain? Am J Surg Pathol 1983, 7:555-565
48. Tapscott SJ, Bennett GS, Holtzer H: Neuronal precursor cells in the chick neural tube express neurofilament proteins. Nature 1981, 292: 836-838
49. Stockhammer G, Manley GT, Johnson R, Rosenblum MK, Samid D, Lieberman FS: Inhibition of proliferation and induction of differentiation in medulloblastoma- and astrocytoma-derived cell lines with phenylacetate. J Neurosurg 1995, 83:672-681
50. Lindenbaum MH, Carbonetto S, Mushynski WE: Nerve growth factor enhances the synthesis, phosphorylation, and metabolic stability of neurofilament protein in PC12 cells. J Biol Chem 1987, 262:605-610
51. Sato N, Hotta K, Waguri S, Nitatori T, Tohyama K, Tsujimoto Y, Uchiyama Y: Neuronal differentiation of PC12 cells as a result of prevention of cell death by bcl-2. J Neurobiol 1994, 25:1227-1234
52. Darzynkiewicz Z, Bruno S, Del Bino G, Gorczyca W, Hotz MA, Lassota P, Traganos F: Features of apoptotic cells measured by flow cytometry. Cytometry 1992, 13:795-808
53. Clarke P: Developmental cell death: morphological diversity and multiple mechanisms. Anat Embryol 1990, 181:195-213
54. Oppenheim R: Cell death during development of the nervous system. Annu Rev Neurosci 1991, 14:453-501
55. Martin SJ, Bradley JG, Cotter TG: HL-60 cells induced to differentiate towards neutrophils subsequently die via apoptosis. Clin Exp Immunol 1990, 79:448-453
56. Ohta H, Sweeney EA, Masamune A, Yatomi Y, Hakomori S-I, Igarashi Y: Induction of apoptosis by shingosine in human leukemic HL-60 cells: a possible endogenous modulator of apoptotic DNA fragmentation occurring during phorbol ester-induced differentiation. Cancer Res 1995, 55:691-697
57. Solary E, Bertrand R, Pommier Y: Apoptosis of human leukemic HL-60 cells induced to differentiate by phorbol ester treatment. Leukemia 1994, 8:792-797
58. Kobayashi Y, Saheki T, Shinozawa T: Induction of PC12 cell death, apoptosis, by a sialoglycopeptide from bovine brain. Biochem Biophys Res Commun 1994, 203:1554-1559
59. Pittman RN, Wang S, DiBenedetto AJ, Mills JC: A system for characterizing cellular and molecular events in programmed neuronal cell death. J Neurosci 1993, 13:3669-3680
60. Darzynkiewicz Z: Apoptosis in antitumor strategies: modulation of cell cycle or differentiation. J Cell Biochem 1995, 58:151-159
61. Canman CE, Gilmer TM, Coutts SB, Kastan MB: Growth factor modulation of p53-mediated growth arrest versus apoptosis. Genes Dev 1995, 9:600-611
62. Baker SJ, Fearon ER, Nigro JM, Hamilton SR, Priesinger AC, Jessup JM, van Tuinene P, Ledbetter DH, Barker DF, Nakamura Y, White R, Vogelstein B: Chromosome 17 deletions and p53 mutations in colorectal carcinomas. Science 1989, 244:217-221
63. Coles C, Thompson AM, Elder PA, Cohen BB, Mackenzie IM, Cranston G, Chetty U, Mackay J, Macdonald M, Nakamura Y, Hoyheim B, Steel CM: Evidence implicating at least two genes on chromosome 17p in breast carcinogenesis. Lancet 1990, 336:761-763
64. James CD, Carlbom E, Dumanski JP, Hansen M, Norden-skjöld M, Collins VP, Cavenee WK: Clonal genomic alterations in glioma malignancy stages. Cancer Res 1988, 48:5546-5551
65. Biegel JA, Burk CD, Barr FG, Emanuel BS: Evidence for a 17p tumor related locus distinct from p53 in pediatric primitive neuroectodermal tumors. Cancer Res 1992, 52:3391-3395
66. Cogen PH, Daneshvar L, Metzger AK, Duyk G, Edwards MSB, Sheffield VC: Involvement of multiple chromosome 17p loci in medulloblastoma tumorigenesis. Am J Hum Genet 1992, 50:584-589
67. Williams GT, Smith CA: Molecular regulation of apoptosis: genetic controls on cell death. Cell 1993, 754:777-779
68. Hockenbery DM, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ: Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990, 348:334-336
69. Jacobson MD, Burne JF, King MP, Miyashita T, Reed JC, Raff MC: Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA. Nature 1993, 361:365-369
70. Reed JC: Bcl-2 and the regulation of programmed cell death. J Cell Biol 1994, 124:1-6
71. Korsmeyer SJ: Regulators of cell death. Trends Genet 1995, 11:101-105
72. Castle VP, Heidelberger KP, Bromberg J, Ou X, Dole M, Nunez G: Expression of the apoptosis-suppressing protein bcl-2 in neuroblastomas is associated with unfavorable histology and N-myc amplification. Am J Pathol 1993, 143:1543-1550
73. Nakasu S, Nakasu Y, Nioka H, Nakajima M, Handa J: Bcl-2 protein expression in tumors of the central nervous system. Acta Neuropathol 1994, 88:520-526
74. Oka H, Satoh Y, Kawano N, Yagishita S, Kameya T: Expression of Bcl-2 gene product in embryonal tumors of the central nervous system. Surg Neurol 1996, 45:230-235